← Back to catalogue
Published

nitazene

vr.tr.nitazene · thing-q126942864

Enable an agent to identify what the registry calls nitazene, assess the evidence about a nitazene-containing material, and determine appropriate analytical, handling and regulatory actions.

Thing Registry Physical world and living systems PHY.OBJ

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 16 findings · 34 questions

Identity and family boundary Establish what nitazene denotes and which chemical entities fall within the entry.

Registry referent

Resolve the intended meaning of the singular registry label.

Singular name resolution

Require evidence before treating nitazene as either one molecule or a collective term.

  1. Does the originating registry record identify a specific structure or use nitazene as a family name? definition
  2. Which original identifier or source record establishes that interpretation? provenance

Structural membership

Define inclusion using explicit chemical and terminological evidence.

Analogue inclusion rule

Record a supported membership rule and its edge cases without relying on a name suffix alone.

  1. Which structural features establish membership under the adopted nitazene definition? definition
  2. How does that definition treat desnitro derivatives and other closely related benzimidazole opioids? boundary
  3. Which related substances already have registry or world-model coverage that this entry should reference? boundary
Chemical form and material Connect an identified nitazene to the composition and condition of material under examination.

Form and content

Qualify identity and quantity by chemical form and matrix.

Analyte and mass basis

Distinguish the identified constituent, its chemical form and the basis used to report content.

  1. Which analogue and chemical form are established in the material? definition
  2. What concentration was measured, in which matrix and on what free-base or salt basis? measurement
  3. Which other constituents were identified, and what remains uncharacterized? measurement

Representativeness and condition

Assess whether tested portions and stored samples support the claimed material state.

Sample integrity

Qualify conclusions by sampling, heterogeneity and evidence of material change.

  1. What sampling evidence supports extending the result from the tested portion to the associated material? measurement
  2. Which storage conditions and elapsed times were recorded, and is stability established for this analogue and matrix? provenance
Analytical identification Determine what an analytical result establishes about nitazene identity and content.

Screening coverage

Record which nitazenes a screening method can assess in the relevant matrix.

Screen interpretation

Bind positive and negative interpretations to validated targets and limitations.

  1. Which named nitazenes were evaluated in the screening method's validation? provenance
  2. What detection threshold, cross-reactivity and matrix limitations apply to this result? measurement
  3. Does the result require confirmatory analysis before assigning a nitazene identity? action

Confirmation and quantification

Establish compound discrimination and the reliability of measured content.

Confirmed analyte evidence

Require traceable reference evidence and an explicit account of unresolved analytical alternatives.

  1. Which reference material and analytical evidence support the assigned analogue? provenance
  2. Can the method distinguish relevant isomers, related analogues and metabolites? boundary
  3. What quantification limit, calibration basis and uncertainty accompany the reported concentration? measurement
Pharmacology and hazard evidence Associate pharmacological and toxicological claims with the particular nitazene and evidence context.

Endpoint-specific activity

Separate receptor binding, functional activity and organism-level effects.

Qualified potency

Keep each activity estimate attached to its experimental endpoint and comparator.

  1. Which receptor-binding or functional endpoint was measured for this exact analogue? measurement
  2. Which assay system, comparator and source support the reported potency? provenance
  3. What limits prevent transferring this result to another analogue or to human exposure? boundary

Toxicological attribution

Assess how strongly observations connect an identified nitazene with adverse effects.

Exposure and effect evidence

Separate confirmed exposure and observed effects from causal conclusions.

  1. Was the parent compound, a metabolite or only a reported exposure identified in the underlying evidence? provenance
  2. How do co-exposures, sampling time and specimen type limit attribution of the observed effects? boundary
  3. Which supported hazard findings require referral to an emergency-response or occupational-safety model? action
Custody and permitted actions Determine which actions are supported for a nitazene-associated material in its actual setting.

Handling and disposition

Connect material evidence to qualified procedures and accountable custody.

Authorized material pathway

Identify appropriate analytical, storage, transfer and disposal pathways without supplying production instructions.

  1. Which approved handling procedure covers the identified or suspected nitazene in this material form? action
  2. Who is authorized to receive, analyze, store or dispose of the material? action
  3. What custody record links the material, tested portion and laboratory result? provenance

Jurisdictional applicability

Attach legal interpretations to chemical identity, place, date and intended activity.

Applicable control evidence

Require a current authoritative basis before asserting that a particular nitazene or activity is controlled or permitted.

  1. Which authoritative instrument applies to this analogue, salt or family in the relevant jurisdiction and on the relevant date? provenance
  2. Does applicability depend on named-compound scheduling, a generic structural definition or another provision? boundary
  3. What authorization is required for the proposed possession, analysis, transfer or disposal? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of nitazene this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of nitazene this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of nitazene this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of nitazene this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of nitazene this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of nitazene this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.OBJ
Other names and narrower kinds
Nitazene

What it is Filled

A nitazene is a synthetic opioid belonging to the substituted 2-benzylbenzimidazole family, many members of which are potent agonists at the μ-opioid receptor.

In scope

  • Nitazene terminology, structural membership and compound identity
  • Chemical form, composition and condition of associated materials
  • Analytical identification, quantification and uncertainty
  • Compound-specific pharmacological and toxicological evidence
  • Evidence required for handling, custody and jurisdiction-specific decisions

Out of scope

  • General opioid classification beyond the relationships needed to distinguish nitazenes
  • Independent models of named analogues unless registry granularity authorizes them
  • Synthesis routes, manufacturing optimization and recreational dosing
  • Patient diagnosis and individualized overdose treatment
  • Drug-market organizations, trafficking events and population surveillance systems

Why it exists Filled

Enable an agent to identify what the registry calls nitazene, assess the evidence about a nitazene-containing material, and determine appropriate analytical, handling and regulatory actions.

Distinguishing features Filled

  • Check structural evidence for the 2-benzylbenzimidazole family associated with nitazene terminology; opioid effects alone do not establish membership. [EUDA](https://www.euda.europa.eu/publications/eu-drug-markets/new-psychoactive-substances/distribution-and-supply/new-opioids_en)
  • Distinguish a family-level label from a named analogue using an explicit chemical structure and identifiers; the word nitazene alone cannot establish one molecular formula.
  • Distinguish nitazene identification from a generic opioid-positive result by checking the assay's named targets and compound-discrimination evidence.
  • Distinguish an identified nitazene constituent from the identity of an entire powder, tablet or mixture using composition evidence.
  • Separate free-base identity, salt identity and measured mass basis before treating two records as equivalent.

What robots and AI may and may not do Filled

Must not

  • Give any synthesis, sourcing, dose or method of use.
  • Help anyone obtain, sell or traffic nitazenes.
  • Present them as safe or as substitutes for prescribed medicines.
  • Identify a person as a user or dealer without evidence.

Only with a human decision

  • Reporting a person to authorities in connection with the drugs.

May

  • Explain what nitazenes are and why public health bodies warn about them, at a general level.
  • Share harm reduction and overdose response information from public health bodies.
  • Direct people to emergency services in a suspected overdose.

Moral aspects Filled

  • Nitazenes are causing overdose deaths, often in people who did not know they took them.
  • People who use drugs deserve accurate safety information and dignity.

Who is affected

  • People who use drugs
  • Families
  • Emergency workers

Owners Filled

Steward

Nobody lawfully owns them outside licensed research; drug control authorities regulate them.

Master systems

  • National controlled substances schedules

Links to other meta-models Filled

parent

  • Q115640245 - registry parent class
  • Q1993952 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.nitazene
  • Wikidata: Q126942864 (https://www.wikidata.org/wiki/Q126942864)

Direct properties required Filled

  • Referent resolution: family-level; compound-resolved; material-associated; unresolved
  • Chemical identity: Named structure linked to verified identifiers and identity evidence
  • Family membership: included; excluded; disputed; unassessed, under a cited definition
  • Chemical form: free base; specified salt; other characterized form; unknown
  • Material concentration: mg/g, mg/mL or mass fraction, with analyte, matrix, chemical basis and uncertainty
  • Analytical conclusion: suspected; screened positive; confirmed; not detected within stated coverage; inconclusive
  • Pharmacological evidence: Endpoint-specific values such as EC50 or Ki in nM, with assay, compound and comparator
  • Material integrity: characterized; heterogeneous; potentially altered; unknown
  • Applicable control: Compound or family linked to an authoritative rule, jurisdiction and effective date

Recognition not applicable Not applicable

Not applicable

Nitazenes have no reliable visual identifying features, and confirming their presence requires chemical analysis.

Capabilities and actions required Filled

  • Resolve a reported nitazene name to a supported chemical identity or retain its ambiguity.
  • Request qualified laboratory confirmation appropriate to the suspected analogue and sample matrix.
  • Compare analytical results while preserving chemical form, units and detection limits.
  • Flag unsupported transfers of potency or toxicity claims between analogues.
  • Route an associated material to authorized storage, analysis, transfer or disposal using applicable evidence.
  • Link a confirmed identification to an existing compound model without creating a duplicate registry concept.

Hazards and failure modes required Filled

  • Can cause fatal breathing depression.
  • Often found unknowingly in other drugs.

Standards and interfaces required Filled

  • Single Convention on Narcotic Drugs, 1961, United Nations, under which several nitazenes are scheduled.

Context of use required Filled

  • Nitazenes are encountered in forensic toxicology, drug surveillance and research on synthetic opioids.
  • Some members occur in unregulated drug supplies, including mixtures and counterfeit medicines whose contents may be unknown to users.
  • Laboratories investigate their identity and presence to support exposure assessment and public health monitoring.

Sources Filled

  1. Wikidata item Q126942864: nitazene - identity and sense of the item
  2. Wikipedia: Nitazenes - general description of the item

Open questions

  • Does vr.tr.nitazene denote the nitazene family or a particular chemical entity in its originating registry source?
  • Which authoritative family definition should govern inclusion of desnitro derivatives and other structurally adjacent compounds?
  • Which existing registry entries or world models already cover this concept or named analogues?
  • Which analytical methods have demonstrated coverage and discrimination for the relevant analogues and matrices?
  • Which compound-specific stability, pharmacology and human toxicology findings are sufficiently supported to populate the model?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q126942864/spec.json